Jellison Retires, Boehnlein New Stryker CFO

Bill Jellison is retiring as Stryker Corporation’s chief financial officer. He will be replaced from within by Glenn Boehnlein, currently CFO for the company’s MedSurg & Neurotechnology division. The transition will take effect on April 1, 2016.

Jellison

Jellison has had a 36-year career, the last three with Stryker and coincided with the tenure of company Chairman and CEO, Kevin Lobo. Lobo and Jellison worked together after the abrupt departure of long time company chief Stephen McMillan.

He began his career with the Donnelly Corporation, where he served in several senior leadership roles advancing to vice president of finance. Prior to joining Stryker, Jellison spent 15 years at Dentsply International, the world’s largest manufacturer of professional dental products, most recently as the company’s senior vice president and CFO. He also spent two years as a senior vice president with full P&L responsibilities for some of Dentsply’s operating divisions located in the U.S., Europe & Asia.

Lobo said, “I want to thank Bill for his leadership since joining Stryker as he helped advance a series of key priorities, including implementing a layered hedging program, executing on a number of acquisitions, and facilitating the establishment of our European regional headquarters. These accomplishments have meaningfully contributed to our success and were achieved while enabling our internal talent pool to develop, including Glenn who has been promoted to CFO.”

Boehnlein

Boehnlein joined Stryker in 2003 as vice president of Finance and IT for the company’s Endoscopy division. He assumed increasing responsibility, including his current role as Group CFO of MSNT, which he assumed in 2011. He began his career with Arthur Andersen, where he became a partner. He then spent three years with Success TV as the company’s CFO before joining Stryker. He holds a bachelor’s and master’s degrees in accounting from Mississippi State University and is a CPA.

Lobo said he was confident in Boehnlein’s ability to lead the company’s finance organization and partner with the broader organization to help Stryker “continue to deliver sales growth at the high end of Med Tech while consistently achieving leveraged earnings gains.”

A company announcement on January 26, 2016 stated that Jellison will pursue his interests of becoming more involved with board roles, having recently joined the board of PolyOne Corporation, and devoting more time to his family.